Company Overview

Development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost effective, accurate and available to all women regardless of age, race and geographic location.

Directors and Management

Mr Mark Douglas Irving Burrows

Non-Executive Director 21/07/2021

Mr Burrows has experience in diagnosis of breast cancer and other cancers. He has career in investment banking both in Australia and the UK. Mark co-founded Baring Brothers Burrows & Co in Australia in the early 80s. In 1999 he was appointed the Managing Director/ Deputy Chairman of ING Barings in London. In 2004, Mark joined Lazard as a Managing Partner and in 2006 returned to Australia and was appointed Lazard Australia's inaugural Chairman. Mark returned to investment banking in 2011 as Vice Chairman of Credit Suisse's Global Investment Bank. During his investment banking career, Mark has been the principal financial advisor to some of the transformative corporate and government transactions in Australia. Mark has served as a non-executive director on several Australasian and UK public companies including Chairman and Deputy Chair of Brambles, Fairfax Media and Telstra. Since the Rio Earth Summit in 1992, Mark has also been supporter of global financial institutions' Private Sector involvement in sustainable development. Over this period, Mark has retained a number of roles advising United Nations, G20 and corporates on climate initiatives relating to the financial sector. From 2017 to 2020, Mark was a Senior Advisor to Macquarie Bank, on climate finance and renewable energy. Mark currently retains a role as a senior advisor to UNEP, UNDP, The Green Finance Initiative in London and is on the Asian Council of The Nature Conservancy. He is also a Senior Advisor to the G20 Sustainability Group.

AO Male

Ms Jayne Andrea Shaw

Executive Chairman,Executive Director 15/02/2010

Ms Shaw has become a Director of Nursing and Chief Executive Officer of two private hospitals in Australia after completion of her training in nursing. Following this, she established an Australian and international consulting business which was sold to Healthsouth, a USA Healthcare company. Jayne then became the Co-founder of Vision Group, an Ophthalmic Doctor equity consolidation model that was successfully listed on the ASX. Jayne joined a number of private healthcare boards involved with specialist consolidation including Cardiology, Orthopaedics, and Women's Health, and continued to work with private equity firms on local and international healthcare transactions. Jayne, together with Ron Phillips, was a co-owner of Sydney Breast Clinic and a co-founder of BCAL. Current board positions are The Woolcock Research Institute, Corum Group (ASX: COO) and Mable Technologies.

Registered Nurse Female

Dr Merilyn Joy Sleigh

Non-Executive Director 31/03/2021

Dr Sleigh has over 30 years of experience as a senior executive and non-executive director in Australia's biotechnology sector. She was, from its foundation, Chief Executive Officer and Managing Director of EvoGenix Limited, a biotech startup company that expanded internationally and listed on the ASX before acquisition by a larger company. She was formerly Dean of the Faculty of Life Sciences, University of NSW; Director of Research & Development at Australian biotech Peptech Ltd and a research scientist and senior manager with CSIRO. She has held non-executive director positions with Mimetica Pty Ltd and Adalta Ltd as well as with ASX listed companies Clover Corporation, and Tyrian Diagnostics Ltd. Other director roles have been with government and not-for-profit organisations, including the Rural Industries Research and Development Corporation and Relationships Australia. She has acted as an adviser and consultant to companies, government, research institutes and investors on technology commercialization. She is also member of the Risk Management Committee of BDX.

BSc, PhD, DipCorpMgt,FAICD,FTSE, Female

Mr Jonathan Alfred Grey Trollip

Non-Executive Director 23/12/2020

Mr Trollip is an experienced Director with over 30 years of commercial, corporate, governance and legal and transactional experience. He is currently non-executive Chairman of ASX listed Global Value Fund Limited, Future Generation Investment Company Limited, Antipodes Global Investment Company Limited, Plato Income Maximser Limited, and Spheria Emerging Companies Limited and a non-executive director of ASX listed Propel Funeral Partners Limited and LSE listed Kore Potash PLC. He has experience in the not-for-profit sector. He is also chairman of the Risk Management Committee of BDX.

BA(Eco),PostGrad(Eco & Law), FAICD, LLM, Male

Hon Ronald (Ron) Anthony Phillips

Non-Executive Director 15/02/2010

The Hon Phillips has been worked for 15 years in the NSW Parliament which included serving as Minister for Health and Deputy Leader of the Opposition. Ron has developed a consulting business in the Health and Aged Care Industry. His business interests included co-owner and Managing Director of Sydney Breast Clinic which he sold to Healthscope. He recently retired as Chair of the Sydney Local Health District and as Director of Westmead IVF. He is also member of the Risk Management Committee of BDX.

AO Male

Top 20 Shareholders

Director Transactions